GH Research
GHRS • NASDAQ
GH Research is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Velichka Valcheva, with a market cap of $815.7M.
CEOVelichka Valcheva
Next Earnings
Upcoming earnings announcement for GH Research
Date
Thursday, May 7, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.27
Earnings History
Past 12 earnings reports for GH Research
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.23Est: -$0.28 | +17.9% | - | — | — |
| Nov 6, 2025 | Q3 2025 | -$0.23Est: -$0.23 | 0.0% | - | — | — |
| Aug 7, 2025 | Q2 2025 | -$0.15Est: -$0.21 | +28.6% | - | — | — |
| May 8, 2025 | Q1 2025 | -$0.19Est: -$0.24 | +20.8% | - | — | — |
| Feb 27, 2025 | Q4 2024 | -$0.17Est: -$0.22 | +22.7% | - | — | — |
| Nov 14, 2024 | Q3 2024 | -$0.23Est: -$0.25 | +8.0% | - | — | — |
| Sep 3, 2024 | Q2 2024 | -$0.20Est: -$0.23 | +13.0% | - | — | — |
| May 3, 2024 | Q1 2024 | -$0.15Est: -$0.22 | +31.8% | - | — | — |
| Feb 29, 2024 | Q4 2023 | -$0.21Est: -$0.20 | -5.0% | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.11Est: -$0.20 | +45.0% | - | — | — |
| Aug 23, 2023 | Q2 2023 | -$0.15Est: -$0.25 | +40.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.21Est: -$0.22 | +4.5% | - | — | — |